nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.194	0.228	CbGbCtD
Halofantrine—CYP3A5—Progesterone—uterine cancer	0.133	0.157	CbGbCtD
Halofantrine—CYP2C8—Progesterone—uterine cancer	0.128	0.151	CbGbCtD
Halofantrine—CYP2D6—Progesterone—uterine cancer	0.0818	0.0964	CbGbCtD
Halofantrine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0785	0.0925	CbGbCtD
Halofantrine—CYP3A5—Etoposide—uterine cancer	0.0597	0.0703	CbGbCtD
Halofantrine—CYP2C8—Etoposide—uterine cancer	0.0574	0.0676	CbGbCtD
Halofantrine—CYP3A4—Progesterone—uterine cancer	0.052	0.0613	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—uterine cancer	0.025	0.0294	CbGbCtD
Halofantrine—CYP3A4—Etoposide—uterine cancer	0.0233	0.0274	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—uterine cancer	0.0159	0.0187	CbGbCtD
Halofantrine—Depressed level of consciousness—Progesterone—uterine cancer	0.00294	0.0194	CcSEcCtD
Halofantrine—Abnormal vision—Progesterone—uterine cancer	0.00266	0.0176	CcSEcCtD
Halofantrine—Sleep disorder—Progesterone—uterine cancer	0.00256	0.0169	CcSEcCtD
Halofantrine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.0147	CcSEcCtD
Halofantrine—Face oedema—Progesterone—uterine cancer	0.00214	0.0141	CcSEcCtD
Halofantrine—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.0135	CcSEcCtD
Halofantrine—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.0128	CcSEcCtD
Halofantrine—Abdominal distension—Progesterone—uterine cancer	0.00192	0.0127	CcSEcCtD
Halofantrine—Rigors—Etoposide—uterine cancer	0.00191	0.0126	CcSEcCtD
Halofantrine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0121	CcSEcCtD
Halofantrine—Pollakiuria—Progesterone—uterine cancer	0.00177	0.0117	CcSEcCtD
Halofantrine—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.0115	CcSEcCtD
Halofantrine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0106	CcSEcCtD
Halofantrine—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00994	CcSEcCtD
Halofantrine—Visual impairment—Progesterone—uterine cancer	0.00147	0.00974	CcSEcCtD
Halofantrine—Tinnitus—Progesterone—uterine cancer	0.00143	0.00942	CcSEcCtD
Halofantrine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00882	CcSEcCtD
Halofantrine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00854	CcSEcCtD
Halofantrine—Back pain—Progesterone—uterine cancer	0.00129	0.00851	CcSEcCtD
Halofantrine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00822	CcSEcCtD
Halofantrine—Ill-defined disorder—Progesterone—uterine cancer	0.00124	0.00816	CcSEcCtD
Halofantrine—Malaise—Progesterone—uterine cancer	0.0012	0.00793	CcSEcCtD
Halofantrine—Palpitations—Progesterone—uterine cancer	0.00118	0.00777	CcSEcCtD
Halofantrine—Stomatitis—Dactinomycin—uterine cancer	0.00117	0.00776	CcSEcCtD
Halofantrine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00771	CcSEcCtD
Halofantrine—Cough—Progesterone—uterine cancer	0.00116	0.00768	CcSEcCtD
Halofantrine—Convulsion—Progesterone—uterine cancer	0.00115	0.00762	CcSEcCtD
Halofantrine—Chest pain—Progesterone—uterine cancer	0.00113	0.00749	CcSEcCtD
Halofantrine—Arthralgia—Progesterone—uterine cancer	0.00113	0.00749	CcSEcCtD
Halofantrine—Myalgia—Progesterone—uterine cancer	0.00113	0.00749	CcSEcCtD
Halofantrine—Discomfort—Progesterone—uterine cancer	0.00112	0.0074	CcSEcCtD
Halofantrine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.0074	CcSEcCtD
Halofantrine—Confusional state—Progesterone—uterine cancer	0.0011	0.00724	CcSEcCtD
Halofantrine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00719	CcSEcCtD
Halofantrine—Anaphylactic shock—Progesterone—uterine cancer	0.00109	0.00718	CcSEcCtD
Halofantrine—Rigors—Epirubicin—uterine cancer	0.00107	0.00707	CcSEcCtD
Halofantrine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00704	CcSEcCtD
Halofantrine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00691	CcSEcCtD
Halofantrine—Anorexia—Progesterone—uterine cancer	0.00104	0.00684	CcSEcCtD
Halofantrine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00679	CcSEcCtD
Halofantrine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00679	CcSEcCtD
Halofantrine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00679	CcSEcCtD
Halofantrine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00671	CcSEcCtD
Halofantrine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000993	0.00656	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00099	0.00654	CcSEcCtD
Halofantrine—Rigors—Doxorubicin—uterine cancer	0.00099	0.00654	CcSEcCtD
Halofantrine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000985	0.00651	CcSEcCtD
Halofantrine—Paraesthesia—Progesterone—uterine cancer	0.000976	0.00645	CcSEcCtD
Halofantrine—Chills—Dactinomycin—uterine cancer	0.00097	0.00641	CcSEcCtD
Halofantrine—Dyspepsia—Progesterone—uterine cancer	0.000957	0.00632	CcSEcCtD
Halofantrine—Decreased appetite—Progesterone—uterine cancer	0.000945	0.00624	CcSEcCtD
Halofantrine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000939	0.0062	CcSEcCtD
Halofantrine—Fatigue—Progesterone—uterine cancer	0.000937	0.00619	CcSEcCtD
Halofantrine—Constipation—Progesterone—uterine cancer	0.00093	0.00614	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000898	0.00593	CcSEcCtD
Halofantrine—Feeling abnormal—Progesterone—uterine cancer	0.000896	0.00592	CcSEcCtD
Halofantrine—Gastrointestinal pain—Progesterone—uterine cancer	0.000889	0.00587	CcSEcCtD
Halofantrine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000885	0.00584	CcSEcCtD
Halofantrine—Ill-defined disorder—Dactinomycin—uterine cancer	0.000874	0.00577	CcSEcCtD
Halofantrine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000867	0.00573	CcSEcCtD
Halofantrine—Urticaria—Progesterone—uterine cancer	0.000864	0.0057	CcSEcCtD
Halofantrine—Abdominal pain—Progesterone—uterine cancer	0.000859	0.00568	CcSEcCtD
Halofantrine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000856	0.00566	CcSEcCtD
Halofantrine—Stomatitis—Etoposide—uterine cancer	0.00085	0.00561	CcSEcCtD
Halofantrine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.00561	CcSEcCtD
Halofantrine—Malaise—Dactinomycin—uterine cancer	0.000849	0.00561	CcSEcCtD
Halofantrine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000842	0.00556	CcSEcCtD
Halofantrine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000812	0.00536	CcSEcCtD
Halofantrine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000806	0.00532	CcSEcCtD
Halofantrine—Myalgia—Dactinomycin—uterine cancer	0.000802	0.00529	CcSEcCtD
Halofantrine—Discomfort—Dactinomycin—uterine cancer	0.000792	0.00523	CcSEcCtD
Halofantrine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000783	0.00517	CcSEcCtD
Halofantrine—Asthenia—Progesterone—uterine cancer	0.00078	0.00515	CcSEcCtD
Halofantrine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000779	0.00514	CcSEcCtD
Halofantrine—Pulmonary oedema—Epirubicin—uterine cancer	0.000778	0.00514	CcSEcCtD
Halofantrine—Pruritus—Progesterone—uterine cancer	0.000769	0.00508	CcSEcCtD
Halofantrine—Abnormal vision—Epirubicin—uterine cancer	0.000762	0.00503	CcSEcCtD
Halofantrine—Diarrhoea—Progesterone—uterine cancer	0.000744	0.00491	CcSEcCtD
Halofantrine—Anorexia—Dactinomycin—uterine cancer	0.000732	0.00484	CcSEcCtD
Halofantrine—Pulmonary oedema—Doxorubicin—uterine cancer	0.00072	0.00475	CcSEcCtD
Halofantrine—Dizziness—Progesterone—uterine cancer	0.000719	0.00475	CcSEcCtD
Halofantrine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000707	0.00467	CcSEcCtD
Halofantrine—Abnormal vision—Doxorubicin—uterine cancer	0.000705	0.00466	CcSEcCtD
Halofantrine—Chills—Etoposide—uterine cancer	0.000702	0.00464	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.0007	0.00462	CcSEcCtD
Halofantrine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000697	0.0046	CcSEcCtD
Halofantrine—Vomiting—Progesterone—uterine cancer	0.000691	0.00456	CcSEcCtD
Halofantrine—Rash—Progesterone—uterine cancer	0.000685	0.00453	CcSEcCtD
Halofantrine—Dermatitis—Progesterone—uterine cancer	0.000685	0.00452	CcSEcCtD
Halofantrine—Headache—Progesterone—uterine cancer	0.000681	0.0045	CcSEcCtD
Halofantrine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00445	CcSEcCtD
Halofantrine—Decreased appetite—Dactinomycin—uterine cancer	0.000668	0.00441	CcSEcCtD
Halofantrine—Fatigue—Dactinomycin—uterine cancer	0.000662	0.00438	CcSEcCtD
Halofantrine—Back pain—Etoposide—uterine cancer	0.000659	0.00435	CcSEcCtD
Halofantrine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000651	0.0043	CcSEcCtD
Halofantrine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000647	0.00427	CcSEcCtD
Halofantrine—Nausea—Progesterone—uterine cancer	0.000646	0.00426	CcSEcCtD
Halofantrine—Feeling abnormal—Dactinomycin—uterine cancer	0.000633	0.00418	CcSEcCtD
Halofantrine—Ill-defined disorder—Etoposide—uterine cancer	0.000632	0.00418	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000628	0.00415	CcSEcCtD
Halofantrine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00414	CcSEcCtD
Halofantrine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000621	0.0041	CcSEcCtD
Halofantrine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000621	0.0041	CcSEcCtD
Halofantrine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000617	0.00408	CcSEcCtD
Halofantrine—Malaise—Etoposide—uterine cancer	0.000615	0.00406	CcSEcCtD
Halofantrine—Face oedema—Epirubicin—uterine cancer	0.000612	0.00404	CcSEcCtD
Halofantrine—Abdominal pain—Dactinomycin—uterine cancer	0.000607	0.00401	CcSEcCtD
Halofantrine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000599	0.00396	CcSEcCtD
Halofantrine—Cough—Etoposide—uterine cancer	0.000595	0.00393	CcSEcCtD
Halofantrine—Convulsion—Etoposide—uterine cancer	0.00059	0.0039	CcSEcCtD
Halofantrine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000585	0.00386	CcSEcCtD
Halofantrine—Chest pain—Etoposide—uterine cancer	0.00058	0.00383	CcSEcCtD
Halofantrine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000579	0.00383	CcSEcCtD
Halofantrine—Discomfort—Etoposide—uterine cancer	0.000573	0.00379	CcSEcCtD
Halofantrine—Face oedema—Doxorubicin—uterine cancer	0.000567	0.00374	CcSEcCtD
Halofantrine—Confusional state—Etoposide—uterine cancer	0.000561	0.0037	CcSEcCtD
Halofantrine—Anaphylactic shock—Etoposide—uterine cancer	0.000556	0.00367	CcSEcCtD
Halofantrine—Abdominal distension—Epirubicin—uterine cancer	0.000552	0.00364	CcSEcCtD
Halofantrine—Asthenia—Dactinomycin—uterine cancer	0.000551	0.00364	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000536	0.00354	CcSEcCtD
Halofantrine—Anorexia—Etoposide—uterine cancer	0.00053	0.0035	CcSEcCtD
Halofantrine—Diarrhoea—Dactinomycin—uterine cancer	0.000526	0.00347	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—uterine cancer	0.000511	0.00337	CcSEcCtD
Halofantrine—Pollakiuria—Epirubicin—uterine cancer	0.000506	0.00334	CcSEcCtD
Halofantrine—Paraesthesia—Etoposide—uterine cancer	0.000499	0.0033	CcSEcCtD
Halofantrine—Vomiting—Dactinomycin—uterine cancer	0.000489	0.00323	CcSEcCtD
Halofantrine—Rash—Dactinomycin—uterine cancer	0.000484	0.0032	CcSEcCtD
Halofantrine—Decreased appetite—Etoposide—uterine cancer	0.000483	0.00319	CcSEcCtD
Halofantrine—Fatigue—Etoposide—uterine cancer	0.000479	0.00317	CcSEcCtD
Halofantrine—Stomatitis—Epirubicin—uterine cancer	0.000476	0.00315	CcSEcCtD
Halofantrine—Constipation—Etoposide—uterine cancer	0.000476	0.00314	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—uterine cancer	0.000469	0.00309	CcSEcCtD
Halofantrine—Feeling abnormal—Etoposide—uterine cancer	0.000458	0.00303	CcSEcCtD
Halofantrine—Nausea—Dactinomycin—uterine cancer	0.000456	0.00301	CcSEcCtD
Halofantrine—Gastrointestinal pain—Etoposide—uterine cancer	0.000455	0.003	CcSEcCtD
Halofantrine—Urticaria—Etoposide—uterine cancer	0.000442	0.00292	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—uterine cancer	0.000441	0.00291	CcSEcCtD
Halofantrine—Abdominal pain—Etoposide—uterine cancer	0.00044	0.0029	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—uterine cancer	0.000423	0.00279	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—uterine cancer	0.000409	0.0027	CcSEcCtD
Halofantrine—Asthenia—Etoposide—uterine cancer	0.000399	0.00264	CcSEcCtD
Halofantrine—Chills—Epirubicin—uterine cancer	0.000394	0.0026	CcSEcCtD
Halofantrine—Pruritus—Etoposide—uterine cancer	0.000393	0.0026	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—uterine cancer	0.000392	0.00259	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—uterine cancer	0.000391	0.00258	CcSEcCtD
Halofantrine—Diarrhoea—Etoposide—uterine cancer	0.000381	0.00251	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—uterine cancer	0.000379	0.0025	CcSEcCtD
Halofantrine—Back pain—Epirubicin—uterine cancer	0.000369	0.00244	CcSEcCtD
Halofantrine—Dizziness—Etoposide—uterine cancer	0.000368	0.00243	CcSEcCtD
Halofantrine—Chills—Doxorubicin—uterine cancer	0.000364	0.00241	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—uterine cancer	0.000363	0.0024	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—uterine cancer	0.000354	0.00234	CcSEcCtD
Halofantrine—Vomiting—Etoposide—uterine cancer	0.000354	0.00234	CcSEcCtD
Halofantrine—Rash—Etoposide—uterine cancer	0.000351	0.00232	CcSEcCtD
Halofantrine—Dermatitis—Etoposide—uterine cancer	0.00035	0.00231	CcSEcCtD
Halofantrine—Headache—Etoposide—uterine cancer	0.000348	0.0023	CcSEcCtD
Halofantrine—Malaise—Epirubicin—uterine cancer	0.000344	0.00227	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—uterine cancer	0.000342	0.00226	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—uterine cancer	0.000338	0.00223	CcSEcCtD
Halofantrine—Cough—Epirubicin—uterine cancer	0.000333	0.0022	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—uterine cancer	0.000331	0.00219	CcSEcCtD
Halofantrine—Nausea—Etoposide—uterine cancer	0.00033	0.00218	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000328	0.00217	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—uterine cancer	0.000325	0.00215	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—uterine cancer	0.000325	0.00215	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—uterine cancer	0.000325	0.00215	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—uterine cancer	0.000321	0.00212	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—uterine cancer	0.000319	0.0021	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—uterine cancer	0.000314	0.00208	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—uterine cancer	0.000312	0.00206	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—uterine cancer	0.000312	0.00206	CcSEcCtD
Halofantrine—Cough—Doxorubicin—uterine cancer	0.000308	0.00204	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—uterine cancer	0.000306	0.00202	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—uterine cancer	0.000301	0.00199	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—uterine cancer	0.000301	0.00199	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—uterine cancer	0.000301	0.00199	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—uterine cancer	0.000297	0.00196	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—uterine cancer	0.000297	0.00196	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—uterine cancer	0.000291	0.00192	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000288	0.0019	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000284	0.00188	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—uterine cancer	0.00028	0.00185	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—uterine cancer	0.000275	0.00182	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—uterine cancer	0.000274	0.00181	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—uterine cancer	0.000271	0.00179	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—uterine cancer	0.000269	0.00177	CcSEcCtD
Halofantrine—Constipation—Epirubicin—uterine cancer	0.000267	0.00176	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000263	0.00174	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—uterine cancer	0.000259	0.00171	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—uterine cancer	0.000257	0.0017	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000255	0.00168	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—uterine cancer	0.000254	0.00168	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—uterine cancer	0.000251	0.00166	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—uterine cancer	0.000249	0.00164	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—uterine cancer	0.000248	0.00164	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—uterine cancer	0.000247	0.00163	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—uterine cancer	0.000246	0.00163	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—uterine cancer	0.000238	0.00157	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000236	0.00156	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—uterine cancer	0.000229	0.00151	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—uterine cancer	0.000228	0.00151	CcSEcCtD
Halofantrine—Asthenia—Epirubicin—uterine cancer	0.000224	0.00148	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—uterine cancer	0.000221	0.00146	CcSEcCtD
Halofantrine—Diarrhoea—Epirubicin—uterine cancer	0.000213	0.00141	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—uterine cancer	0.000207	0.00137	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—uterine cancer	0.000206	0.00136	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—uterine cancer	0.000204	0.00135	CcSEcCtD
Halofantrine—Vomiting—Epirubicin—uterine cancer	0.000198	0.00131	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—uterine cancer	0.000197	0.0013	CcSEcCtD
Halofantrine—Rash—Epirubicin—uterine cancer	0.000197	0.0013	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—uterine cancer	0.000196	0.0013	CcSEcCtD
Halofantrine—Headache—Epirubicin—uterine cancer	0.000195	0.00129	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—uterine cancer	0.000191	0.00126	CcSEcCtD
Halofantrine—Nausea—Epirubicin—uterine cancer	0.000185	0.00122	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—uterine cancer	0.000183	0.00121	CcSEcCtD
Halofantrine—Rash—Doxorubicin—uterine cancer	0.000182	0.0012	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—uterine cancer	0.000182	0.0012	CcSEcCtD
Halofantrine—Headache—Doxorubicin—uterine cancer	0.000181	0.00119	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—uterine cancer	0.000171	0.00113	CcSEcCtD
